HEADER MAMMALIAN PCB-BINDING PROTEIN 01-SEP-95 1UTR TITLE UTEROGLOBIN-PCB COMPLEX (REDUCED FORM) COMPND MOL_ID: 1; COMPND 2 MOLECULE: UTEROGLOBIN; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: MAMMALIAN PCB-BINDING PROTEIN; COMPND 5 ENGINEERED: YES; COMPND 6 OTHER_DETAILS: TEMPERATURE=30C, PH=7.8, 25 MM PHOSPHATE BUFFER SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: RATTUS NORVEGICUS; SOURCE 3 ORGANISM_COMMON: NORWAY RAT; SOURCE 4 ORGANISM_TAXID: 10116; SOURCE 5 ORGAN: LUNG; SOURCE 6 GENE: POTENTIAL; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS UTEROGLOBIN, CLARA CELL 17 KDA PROTEIN (CC10), PHOSPHOLIPASE A2 KEYWDS 2 INHIBITOR, CLARA CELL PHOSPHOLIPID-BINDING PROTEIN, PROGESTERONE KEYWDS 3 BINDING, MAMMALIAN PCB-BINDING PROTEIN EXPDTA SOLUTION NMR AUTHOR T.HARD,H.J.BARNES,C.LARSSON,J.-A.GUSTAFSSON,J.LUND REVDAT 4 22-MAY-24 1UTR 1 REMARK REVDAT 3 02-MAR-22 1UTR 1 REMARK REVDAT 2 24-FEB-09 1UTR 1 VERSN REVDAT 1 07-DEC-95 1UTR 0 JRNL AUTH T.HARD,H.J.BARNES,C.LARSSON,J.A.GUSTAFSSON,J.LUND JRNL TITL SOLUTION STRUCTURE OF A MAMMALIAN PCB-BINDING PROTEIN IN JRNL TITL 2 COMPLEX WITH A PCB. JRNL REF NAT.STRUCT.BIOL. V. 2 983 1995 JRNL REFN ISSN 1072-8368 JRNL PMID 7583672 JRNL DOI 10.1038/NSB1195-983 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH R.DUNKEL,G.VRIEND,M.BEATO,G.SUSKE REMARK 1 TITL PROGESTERONE BINDING TO UTEROGLOBIN: TWO ALTERNATIVE REMARK 1 TITL 2 CONFORMATIONS OF THE LIGAND REMARK 1 REF PROTEIN ENG. V. 8 71 1995 REMARK 1 REFN ISSN 0269-2139 REMARK 1 REFERENCE 2 REMARK 1 AUTH O.ANDERSSON,L.NORDLUND-MOELLER,H.J.BARNES,J.LUND REMARK 1 TITL HETEROLOGOUS EXPRESSION OF HUMAN UTEROGLOBIN (SLASH) REMARK 1 TITL 2 POLYCHLORINATED BIPHENYL-BINDING PROTEIN REMARK 1 REF J.BIOL.CHEM. V. 269 19081 1994 REMARK 1 REFN ISSN 0021-9258 REMARK 1 REFERENCE 3 REMARK 1 AUTH L.NORDLUND-MOELLER,O.ANDERSSON,R.AHLGREN,J.SCHILLING, REMARK 1 AUTH 2 M.GILLNER,J.-A.GUSTAFSSON,J.LUND REMARK 1 TITL CLONING, STRUCTURE, AND EXPRESSION OF A RAT BINDING PROTEIN REMARK 1 TITL 2 FOR POLYCHLORINATED BIPHENYLS REMARK 1 REF J.MOL.BIOL. V. 224 442 1992 REMARK 1 REFN ISSN 0022-2836 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.1 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1UTR COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000176985. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : NULL REMARK 210 PH : NULL REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : NULL REMARK 210 SAMPLE CONTENTS : NULL REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : NULL REMARK 210 SPECTROMETER FIELD STRENGTH : NULL REMARK 210 SPECTROMETER MODEL : NULL REMARK 210 SPECTROMETER MANUFACTURER : NULL REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NULL REMARK 210 METHOD USED : NULL REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : NULL REMARK 210 CONFORMERS, NUMBER SUBMITTED : 1 REMARK 210 CONFORMERS, SELECTION CRITERIA : NULL REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : NULL REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 465 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 RES C SSSEQI REMARK 465 MET A -18 REMARK 465 LYS A -17 REMARK 465 ILE A -16 REMARK 465 ALA A -15 REMARK 465 ILE A -14 REMARK 465 THR A -13 REMARK 465 ILE A -12 REMARK 465 THR A -11 REMARK 465 VAL A -10 REMARK 465 LEU A -9 REMARK 465 MET A -8 REMARK 465 LEU A -7 REMARK 465 SER A -6 REMARK 465 ILE A -5 REMARK 465 CYS A -4 REMARK 465 CYS A -3 REMARK 465 SER A -2 REMARK 465 SER A -1 REMARK 465 ALA A 0 REMARK 465 SER A 1 REMARK 465 SER A 2 REMARK 465 ASP A 3 REMARK 465 GLU A 72 REMARK 465 GLN A 73 REMARK 465 ASP A 74 REMARK 465 LEU A 75 REMARK 465 ARG A 76 REMARK 465 VAL A 77 REMARK 465 MET B -18 REMARK 465 LYS B -17 REMARK 465 ILE B -16 REMARK 465 ALA B -15 REMARK 465 ILE B -14 REMARK 465 THR B -13 REMARK 465 ILE B -12 REMARK 465 THR B -11 REMARK 465 VAL B -10 REMARK 465 LEU B -9 REMARK 465 MET B -8 REMARK 465 LEU B -7 REMARK 465 SER B -6 REMARK 465 ILE B -5 REMARK 465 CYS B -4 REMARK 465 CYS B -3 REMARK 465 SER B -2 REMARK 465 SER B -1 REMARK 465 ALA B 0 REMARK 465 SER B 1 REMARK 465 SER B 2 REMARK 465 ASP B 3 REMARK 465 GLU B 72 REMARK 465 GLN B 73 REMARK 465 ASP B 74 REMARK 465 LEU B 75 REMARK 465 ARG B 76 REMARK 465 VAL B 77 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 8 -26.67 168.19 REMARK 500 GLU A 20 157.55 173.84 REMARK 500 SER A 21 -45.10 84.28 REMARK 500 ALA A 33 179.83 -49.38 REMARK 500 SER A 34 -90.94 -60.55 REMARK 500 PRO A 51 -165.42 -58.70 REMARK 500 LEU A 66 -71.95 -90.49 REMARK 500 PRO A 69 -160.07 -60.21 REMARK 500 LEU A 70 -168.55 60.64 REMARK 500 PHE B 8 -26.74 168.18 REMARK 500 GLU B 20 157.57 173.84 REMARK 500 SER B 21 -44.94 84.28 REMARK 500 ALA B 33 179.77 -49.37 REMARK 500 SER B 34 -90.89 -60.56 REMARK 500 PRO B 51 -165.50 -58.72 REMARK 500 LEU B 66 -71.91 -90.49 REMARK 500 PRO B 69 -160.05 -60.27 REMARK 500 LEU B 70 -168.59 60.60 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PCB A 78 DBREF 1UTR A -18 77 UNP P17559 UTER_RAT 1 96 DBREF 1UTR B -18 77 UNP P17559 UTER_RAT 1 96 SEQRES 1 A 96 MET LYS ILE ALA ILE THR ILE THR VAL LEU MET LEU SER SEQRES 2 A 96 ILE CYS CYS SER SER ALA SER SER ASP ILE CYS PRO GLY SEQRES 3 A 96 PHE LEU GLN VAL LEU GLU ALA LEU LEU LEU GLY SER GLU SEQRES 4 A 96 SER ASN TYR GLU ALA ALA LEU LYS PRO PHE ASN PRO ALA SEQRES 5 A 96 SER ASP LEU GLN ASN ALA GLY THR GLN LEU LYS ARG LEU SEQRES 6 A 96 VAL ASP THR LEU PRO GLN GLU THR ARG ILE ASN ILE VAL SEQRES 7 A 96 LYS LEU THR GLU LYS ILE LEU THR SER PRO LEU CYS GLU SEQRES 8 A 96 GLN ASP LEU ARG VAL SEQRES 1 B 96 MET LYS ILE ALA ILE THR ILE THR VAL LEU MET LEU SER SEQRES 2 B 96 ILE CYS CYS SER SER ALA SER SER ASP ILE CYS PRO GLY SEQRES 3 B 96 PHE LEU GLN VAL LEU GLU ALA LEU LEU LEU GLY SER GLU SEQRES 4 B 96 SER ASN TYR GLU ALA ALA LEU LYS PRO PHE ASN PRO ALA SEQRES 5 B 96 SER ASP LEU GLN ASN ALA GLY THR GLN LEU LYS ARG LEU SEQRES 6 B 96 VAL ASP THR LEU PRO GLN GLU THR ARG ILE ASN ILE VAL SEQRES 7 B 96 LYS LEU THR GLU LYS ILE LEU THR SER PRO LEU CYS GLU SEQRES 8 B 96 GLN ASP LEU ARG VAL HET PCB A 78 34 HETNAM PCB 4,4'-BIS([H]METHYLSULFONYL)-2,2',5,5'- HETNAM 2 PCB TETRACHLOROBIPHENYL FORMUL 3 PCB C14 H10 CL4 O4 S2 HELIX 1 1 LEU A 9 LEU A 15 1 7 HELIX 2 2 ASN A 22 LYS A 28 1 7 HELIX 3 3 ASP A 35 THR A 49 1 15 HELIX 4 4 GLU A 53 ILE A 65 1 13 HELIX 5 5 LEU B 9 LEU B 15 1 7 HELIX 6 6 ASN B 22 LYS B 28 1 7 HELIX 7 7 ASP B 35 THR B 49 1 15 HELIX 8 8 GLU B 53 ILE B 65 1 13 SITE 1 AC1 17 PHE A 8 VAL A 11 LEU A 15 TYR A 23 SITE 2 AC1 17 GLY A 40 LEU A 43 ILE A 58 LEU A 61 SITE 3 AC1 17 THR A 62 PHE B 8 VAL B 11 TYR B 23 SITE 4 AC1 17 GLY B 40 LEU B 43 ILE B 58 LEU B 61 SITE 5 AC1 17 THR B 62 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000